<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/21/823" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/21/823/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/21/823/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_823"><akn:num>823</akn:num><akn:heading>Registration requirements</akn:heading><akn:content><akn:p>§ 823. Registration requirements(a) Manufacturers of controlled substances in schedule I or IIThe Attorney General shall register an applicant to manufacture controlled substances in schedule I or II if he determines that such registration is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. In determining the public interest, the following factors shall be considered:(1) maintenance of effective controls against diversion of particular controlled substances and any controlled substance in schedule I or II compounded therefrom into other than legitimate medical, scientific, research, or industrial channels, by limiting the importation and bulk manufacture of such controlled substances to a number of establishments which can produce an adequate and uninterrupted supply of these substances under adequately competitive conditions for legitimate medical, scientific, research, and industrial purposes;

(2) compliance with applicable State and local law;

(3) promotion of technical advances in the art of manufacturing these substances and the development of new substances;

(4) prior conviction record of applicant under Federal and State laws relating to the manufacture, distribution, or dispensing of such substances;

(5) past experience in the manufacture of controlled substances, and the existence in the establishment of effective control against diversion; and

(6) such other factors as may be relevant to and consistent with the public health and safety.


(b) Distributors of controlled substances in schedule I or IIThe Attorney General shall register an applicant to distribute a controlled substance in schedule I or II unless he determines that the issuance of such registration is inconsistent with the public interest. In determining the public interest, the following factors shall be considered:(1) maintenance of effective control against diversion of particular co</akn:p></akn:content><akn:subsection eId="subsec_823_a"><akn:num>(a)</akn:num><akn:heading>Manufacturers of controlled substances in schedule I or II</akn:heading><akn:content><akn:p>(a) Manufacturers of controlled substances in schedule I or II The Attorney General shall register an applicant to manufacture controlled substances in schedule I or II if he determines that such registration is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. In determining the public interest, the following factors shall be considered:</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_823_b"><akn:num>(b)</akn:num><akn:heading>Distributors of controlled substances in schedule I or II</akn:heading><akn:content><akn:p>(b) Distributors of controlled substances in schedule I or II The Attorney General shall register an applicant to distribute a controlled substance in schedule I or II unless he determines that the issuance of such registration is inconsistent with the public interest. In determining the public interest, the following factors shall be considered:</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_823_c"><akn:num>(c)</akn:num><akn:heading>Manufacturers of marijuana for research purposes</akn:heading><akn:content><akn:p>(c) Manufacturers of marijuana for research purposes</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_823_d"><akn:num>(d)</akn:num><akn:heading>Limits of authorized activities</akn:heading><akn:content><akn:p>(d) Limits of authorized activities Registration granted under subsections (a) and (b) of this section shall not entitle a registrant to (1) manufacture or distribute controlled substances in schedule I or II other than those specified in the registration, or (2) manufacture any quantity of those controlled substances in excess of the quota assigned pursuant to section 826 of this title.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_823_e"><akn:num>(e)</akn:num><akn:heading>Manufacturers of controlled substances in schedule III, IV, or V</akn:heading><akn:content><akn:p>(e) Manufacturers of controlled substances in schedule III, IV, or V The Attorney General shall register an applicant to manufacture controlled substances in schedule III, IV, or V, unless he determines that the issuance of such registration is inconsistent with the public interest. In determining the public interest, the following factors shall be considered:</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_823_f"><akn:num>(f)</akn:num><akn:heading>Distributors of controlled substances in schedule III, IV, or V</akn:heading><akn:content><akn:p>(f) Distributors of controlled substances in schedule III, IV, or V The Attorney General shall register an applicant to distribute controlled substances in schedule III, IV, or V, unless he determines that the issuance of such registration is inconsistent with the public interest. In determining the public interest, the following factors shall be considered:</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_823_g"><akn:num>(g)</akn:num><akn:heading>Research by practitioners; pharmacies; research applications; construction of Article 7 of the Convention on Psychotropic Substances</akn:heading><akn:content><akn:p>(g) Research by practitioners; pharmacies; research applications; construction of Article 7 of the Convention on Psychotropic Substances</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_823_h"><akn:num>(h)</akn:num><akn:heading>Practitioners dispensing narcotic drugs for narcotic treatment; annual registration; separate registration; qualifications</akn:heading><akn:content><akn:p>(h) Practitioners dispensing narcotic drugs for narcotic treatment; annual registration; separate registration; qualifications Practitioners who dispense narcotic drugs (other than narcotic drugs in schedule III, IV, or V) to individuals for maintenance treatment or detoxification treatment shall obtain annually a separate registration for that purpose. The Attorney General shall register an applicant to dispense narcotic drugs to individuals for maintenance treatment or detoxification treatment (or both)—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_823_i"><akn:num>(i)</akn:num><akn:heading>Applicants for distribution of list I chemicals</akn:heading><akn:content><akn:p>(i) Applicants for distribution of list I chemicals The Attorney General shall register an applicant to distribute a list I chemical unless the Attorney General determines that registration of the applicant is inconsistent with the public interest. Registration under this subsection shall not be required for the distribution of a drug product that is exempted under clause (iv) or (v) of section 802(39)(A) of this title. In determining the public interest for the purposes of this subsection, the Attorney General shall consider—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_823_j"><akn:num>(j)</akn:num><akn:heading>Registration to manufacture certain controlled substances for use only in a clinical trial</akn:heading><akn:content><akn:p>(j) Registration to manufacture certain controlled substances for use only in a clinical trial</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>